Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant Chemotherapy
Clinical trial NCT07410234 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07410234
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-21
- Primary completion
- 2028-02-21
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.